2020
Identification and Management of Opioid Use Disorder in Primary Care: an Update
Donroe JH, Bhatraju EP, Tsui JI, Edelman EJ. Identification and Management of Opioid Use Disorder in Primary Care: an Update. Current Psychiatry Reports 2020, 22: 23. PMID: 32285215, DOI: 10.1007/s11920-020-01149-0.BooksMeSH KeywordsBuprenorphineHumansNorth AmericaOpiate Substitution TreatmentOpioid-Related DisordersPrimary Health CareConceptsOffice-based opioid treatmentOpioid use disorderPrimary care providersUse disordersRecent FindingsThe prevalenceTreatment retention ratesCare of patientsPrimary care practicesDiagnosis of patientsPurpose of ReviewTheFindingsThe prevalenceOpioid treatmentRecent literature pertainingPrimary careComparable outcomesCare providersPatientsCare practicesAmbulatory practiceAddiction medicineCarePrevalenceLiterature pertainingDisordersTreatment
2018
Narrowing the treatment gap in managing opioid use disorder
Donroe JH, Tetrault JM. Narrowing the treatment gap in managing opioid use disorder. Canadian Medical Association Journal 2018, 190: e236-e237. PMID: 29507154, PMCID: PMC5837871, DOI: 10.1503/cmaj.180209.Peer-Reviewed Original ResearchAddressing discordant quantitative urine buprenorphine and norbuprenorphine levels: Case examples in opioid use disorder
Holt SR, Donroe JH, Cavallo DA, Tetrault JM. Addressing discordant quantitative urine buprenorphine and norbuprenorphine levels: Case examples in opioid use disorder. Drug And Alcohol Dependence 2018, 186: 171-174. PMID: 29579725, DOI: 10.1016/j.drugalcdep.2017.12.040.Peer-Reviewed Original ResearchConceptsOngoing illicit drug usePatient-provider relationshipOpioid use disorderIllicit drug useUse disordersUrine adulterationTreatment planDrug useQuantitative urine testingMethadone treatment programsSubstance use disordersNorbuprenorphine levelsUrine buprenorphineUrine testingPatientsTreatment programNonjudgmental approachUrine samplesTherapeutic allianceDiscordant levelsBuprenorphineDisordersUrineNorbuprenorphineLevels
2017
Interpreting quantitative urine buprenorphine and norbuprenorphine levels in office-based clinical practice
Donroe JH, Holt SR, O’Connor P, Sukumar N, Tetrault JM. Interpreting quantitative urine buprenorphine and norbuprenorphine levels in office-based clinical practice. Drug And Alcohol Dependence 2017, 180: 46-51. PMID: 28866369, DOI: 10.1016/j.drugalcdep.2017.07.040.Peer-Reviewed Original ResearchConceptsOpioid use disorderUrine buprenorphineNorbuprenorphine levelsUrine adulterationAddiction treatment clinicsTreatment clinicsBuprenorphine medicationSublingual buprenorphineBuprenorphine treatmentTreatment cohortsRetrospective studyUrine specimenBuprenorphineUse disordersPatientsClinical practiceUrine samplesUrineClinicTreatmentMedicationsLevelsNorBUPCohortSuspicion
2016
Caring for patients with opioid use disorder in the hospitalCaring for patients with opioid use disorder in the hospital
Donroe JH, Holt SR, Tetrault JM. Caring for patients with opioid use disorder in the hospitalCaring for patients with opioid use disorder in the hospital. Canadian Medical Association Journal 2016, 188: cmaj.160290. PMID: 27647616, PMCID: PMC5135493, DOI: 10.1503/cmaj.160290.Peer-Reviewed Original Research